Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ivermectin
- Therapeutic area
- Anti-infectives
- Drug class
- Antiparasitic medicines
- ATC
- P02CF
- Strength
- 3 mg
- Dosage form
- Tablet
- Pack
- 2x10
- Registration no.
- 057558
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-11-12 02:58
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Mectimite (Ivermectin) is used for
Ivermectin is an antiparasitic medicine (an anthelmintic). It kills certain parasitic worms and mites. As a tablet it is a prescription medicine, and the doctor chooses it for a confirmed or suspected parasite infection. It does not prevent these infections.
- Strongyloidiasis, an infection of the gut with a roundworm called Strongyloides
- Infection of the blood with young filarial worms (lymphatic filariasis); it does not kill the adult worms
- Onchocerciasis (river blindness)
- Scabies, when a doctor has confirmed or suspects it
- Some other worm infections, and head or pubic lice (MedlinePlus)
- In the UK, tablets for difficult-to-treat scabies have been used by specialists for people when other treatments have failed or cannot be used
Get medical help straight away if
- Get urgent help for blistering or peeling skin, mouth or eye sores, or target-like or circular patches on the body, sometimes after fever and flu-like symptoms (possible Stevens-Johnson syndrome or toxic epidermal necrolysis). Do not take it again if you have had this.
- Get emergency help for signs of a severe allergic reaction, such as sudden fever, rash or itching, or trouble breathing.
- Get urgent help for sleepiness, confusion, disorientation, decreased consciousness or coma.
- Get urgent help for blood in the urine, or yellow skin or eyes with signs of liver inflammation (hepatitis).
Side effects, warnings and interactions for Ivermectin
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Ivermectin
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Ivermectin is right for you and the dose.
- Scabies: Tablets that work about as well as permethrin cream
- Worm infections (intestinal helminths): The main medicine for Strongyloides, and an alternative for roundworm and whipworm. WHO excludes pregnant women from ivermectin campaigns, and its safety in children under 15 kg is unclear. Breastfeeding women are treated only when untreated infection is the bigger risk
About Mectimite 3 mg tablet
Mectimite 3 mg tablet contains Ivermectin 3 mg. It is registered with DRAP by Mass Pharma (Pvt) Ltd (registration no. 057558). Its official price is PKR 660.90 for a pack of 2x10, about PKR 33.05 per tablet. The price changed from PKR 629.79 to PKR 660.90 on 20 August 2026. Mectimite is also available as 6 mg tablet. 7 other brands of Ivermectin 3 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Mectimite
All 7 other brands of Ivermectin 3 mg tablet in Pakistan
These 7 brands are alternatives (substitutes) to Mectimite: each contains Ivermectin 3 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is IVREA (Maxitech Pharma (Pvt) Ltd) at PKR 24.29 per tablet; the highest is Ivermec at PKR 34.12. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| IVREA | Maxitech Pharma (Pvt) Ltd | 20's | PKR 485.85 | PKR 24.29 / tablet |
| Mectin | Highnoon Laboratories Ltd | 6 | PKR 191.39 | PKR 31.90 / tablet |
| Iveetin | Horizon Healthcare (pvt.) ltd | 20’s | PKR 638.30 | PKR 31.92 / tablet |
| Mactovin | Valor Pharmaceuticals | 2x10's | PKR 638.30 | PKR 31.92 / tablet |
| Mectin | Panacea Pharmaceuticals | 20 | PKR 660.90 | PKR 33.05 / tablet |
| Scabi-Mect | Seatle Private Limited | 20's | PKR 668.48 | PKR 33.42 / tablet |
| Ivermec | M/s. Genix Pharma (Pvt) Ltd | 20's | PKR 682.48 | PKR 34.12 / tablet |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Mectimite, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Mass Pharma (Pvt) Ltd., Lahore
- DRAP registration
- 057558
- Phone
- +92 42 35824881-4; +92 322 4873081
- mass@masspharma.com
- Website
- https://masspharma.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
PKR 629.79 to 660.90 (+4.9%) between 5 Sep 2025 and 20 Aug 2026 · 2 official price records · pack 2x10
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Mectimite 3 mg, 2x10: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/mectimite-3-mg-057558-2x10-mass-pharma-pvt-ltd/ (accessed 12 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 660.90 | 2026-08-20 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 629.79 | 2025-09-05 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Cite this record
Medicine record · DRAP registration 057558Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.
